BioArray News GenomeWeb News Premium Content Existing subscribers login here. New to BioArray News? For a trial subscription click here.

Eyeing Reward Era for Array-Based Pharma
R&D Services, ShanghaiBio Preps for US IPO

[December 11, 2007]

By Justin Petrone

ShanghaiBio plans to use the proceeds from its proposed initial public offering to support its transformation from an array services provider to a contract research organization for global pharmaceutical R&D efforts.

Login | Subscribe